Vascular Biogenics Company

Vascular Biogenics Ltd operating as VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer.
Technology: B2B, Health Care
Industry: AgeTech
Headquarters: Modi’in, Israel
Founded Date: 2000
Employees Number: Above 20
Funding Status: N/A

Visit Website
Register and Claim Ownership